CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater.
Calcitonin gene-related peptide
Cerebrospinal fluid
Jugular plasma
Meningeal blood flow
Primary headaches
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
08 Sep 2021
08 Sep 2021
Historique:
received:
16
02
2021
accepted:
31
08
2021
entrez:
9
9
2021
pubmed:
10
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
Calcitonin gene-related peptide (CGRP) is released from activated meningeal afferent fibres in the cranial dura mater, which likely accompanies severe headache attacks. Increased CGRP levels have been observed in different extracellular fluid compartments during primary headaches such as migraine but it is not entirely clear how CGRP is drained from the meninges. We have used an in vivo preparation of the rat to examine after which time and at which concentration CGRP applied onto the exposed parietal dura mater appears in the jugular venous blood and the cerebrospinal fluid (CSF) collected from the cisterna magna. Recordings of meningeal (dural) and cortical (pial) blood flow were used to monitor the vasodilatory effect of CGRP. In a new ex vivo preparation we examined how much of a defined CGRP concentration applied to the arachnoidal side penetrates the dura. CGRP concentrations were determined with an approved enzyme immunoassay. CGRP levels in the jugular plasma in vivo were slightly elevated compared to baseline values 5-20 min after dural application of CGRP (10 μM), in the CSF a significant three-fold increase was seen after 35 min. Meningeal but not cortical blood flow showed significant increases. The spontaneous CGRP release from the dura mater ex vivo was above the applied low concentration of 1 pM. CGRP at 1 nM did only partly penetrate the dura. We conclude that only a small fraction of CGRP applied onto the dura mater reaches the jugular blood and, in a delayed manner, also the CSF. The dura mater may constitute a barrier for CGRP and limits diffusion into the CSF of the subarachnoidal space, where the CGRP concentration is too low to cause vasodilatation.
Sections du résumé
BACKGROUND
BACKGROUND
Calcitonin gene-related peptide (CGRP) is released from activated meningeal afferent fibres in the cranial dura mater, which likely accompanies severe headache attacks. Increased CGRP levels have been observed in different extracellular fluid compartments during primary headaches such as migraine but it is not entirely clear how CGRP is drained from the meninges.
METHODS
METHODS
We have used an in vivo preparation of the rat to examine after which time and at which concentration CGRP applied onto the exposed parietal dura mater appears in the jugular venous blood and the cerebrospinal fluid (CSF) collected from the cisterna magna. Recordings of meningeal (dural) and cortical (pial) blood flow were used to monitor the vasodilatory effect of CGRP. In a new ex vivo preparation we examined how much of a defined CGRP concentration applied to the arachnoidal side penetrates the dura. CGRP concentrations were determined with an approved enzyme immunoassay.
RESULTS
RESULTS
CGRP levels in the jugular plasma in vivo were slightly elevated compared to baseline values 5-20 min after dural application of CGRP (10 μM), in the CSF a significant three-fold increase was seen after 35 min. Meningeal but not cortical blood flow showed significant increases. The spontaneous CGRP release from the dura mater ex vivo was above the applied low concentration of 1 pM. CGRP at 1 nM did only partly penetrate the dura.
CONCLUSIONS
CONCLUSIONS
We conclude that only a small fraction of CGRP applied onto the dura mater reaches the jugular blood and, in a delayed manner, also the CSF. The dura mater may constitute a barrier for CGRP and limits diffusion into the CSF of the subarachnoidal space, where the CGRP concentration is too low to cause vasodilatation.
Identifiants
pubmed: 34496764
doi: 10.1186/s10194-021-01320-9
pii: 10.1186/s10194-021-01320-9
pmc: PMC8424805
doi:
Substances chimiques
Calcitonin
9007-12-9
Calcitonin Gene-Related Peptide
JHB2QIZ69Z
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105Informations de copyright
© 2021. The Author(s).
Références
Russell FA, King R, Smillie S-J et al (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94:1099–1142. https://doi.org/10.1152/physrev.00034.2013
doi: 10.1152/physrev.00034.2013
pubmed: 25287861
pmcid: 4187032
Bennett MM, Amara SG (1992) Molecular mechanisms of cell-specific and regulated expression of the calcitonin/ a-CGRP and b-CGRP genes. Ann N Y Acad Sci 657:36–49. https://doi.org/10.1111/j.1749-6632.1992.tb22755.x
doi: 10.1111/j.1749-6632.1992.tb22755.x
pubmed: 1637094
Lennerz JK, Rühle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277–1299. https://doi.org/10.1002/cne.21607
doi: 10.1002/cne.21607
pubmed: 18186028
Eftekhari S, Edvinsson L (2011) Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 12:112. https://doi.org/10.1186/1471-2202-12-112
doi: 10.1186/1471-2202-12-112
pubmed: 22074408
pmcid: 3282678
Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain Off J Am Pain Soc 14:1289–1303. https://doi.org/10.1016/j.jpain.2013.03.010
doi: 10.1016/j.jpain.2013.03.010
Henry MA, Johnson LR, Nousek-Goebl N, Westrum LE (1996) Light microscopic localization of calcitonin gene-related peptide in the normal feline trigeminal system and following retrogasserian rhizotomy. J Comp Neurol 365:526–540 https://doi.org/10.1002/(SICI)1096-9861(19960219)365:4<526::AID-CNE2>3.0.CO;2-6
doi: 10.1002/(SICI)1096-9861(19960219)365:4<526::AID-CNE2>3.0.CO;2-6
Messlinger K, Fischer MJM, Lennerz JK (2011) Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med 60:82–89
doi: 10.2302/kjm.60.82
Jansen I, Mortensen A, Edvinsson L (1992) Characterization of calcitonin gene-related peptide receptors in human cerebral vessels. Vasomotor responses and cAMP accumulation. Ann N Y Acad Sci 657:435–440. https://doi.org/10.1111/j.1749-6632.1992.tb22793.x
doi: 10.1111/j.1749-6632.1992.tb22793.x
pubmed: 1322097
Eberhardt M, Hoffmann T, Sauer SK et al (2008) Calcitonin gene-related peptide release from intact isolated dorsal root and trigeminal ganglia. Neuropeptides 42:311–317. https://doi.org/10.1016/j.npep.2008.01.002
doi: 10.1016/j.npep.2008.01.002
pubmed: 18328558
Hoffmann J, Wecker S, Neeb L et al (2012) Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF. Cephalalgia Int J Headache 32:659–667. https://doi.org/10.1177/0333102412447701
doi: 10.1177/0333102412447701
Kageneck C, Nixdorf-Bergweiler BE, Messlinger K, Fischer MJ (2014) Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate. J Headache Pain 15:7. https://doi.org/10.1186/1129-2377-15-7
doi: 10.1186/1129-2377-15-7
pubmed: 24506953
pmcid: 3922191
Cornelison LE, Hawkins JL, Durham PL (2016) Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons. Neuroscience 339:491–501. https://doi.org/10.1016/j.neuroscience.2016.10.013
doi: 10.1016/j.neuroscience.2016.10.013
pubmed: 27746346
Dux M, Will C, Eberhardt M et al (2017) Stimulation of rat cranial dura mater with potassium chloride causes CGRP release into the cerebrospinal fluid and increases medullary blood flow. Neuropeptides. https://doi.org/10.1016/j.npep.2017.02.080
Marics B, Peitl B, Pázmándi K et al (2017) Diet-induced obesity enhances TRPV1-mediated neurovascular reactions in the dura mater. Headache 57:441–454. https://doi.org/10.1111/head.13033
doi: 10.1111/head.13033
pubmed: 28133727
Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193–196. https://doi.org/10.1002/ana.410230214
doi: 10.1002/ana.410230214
pubmed: 2454066
Awawdeh L, Lundy FT, Shaw C et al (2002) Quantitative analysis of substance P, neurokinin a and calcitonin gene-related peptide in pulp tissue from painful and healthy human teeth. Int Endod J 35:30–36. https://doi.org/10.1046/j.1365-2591.2002.00451.x
doi: 10.1046/j.1365-2591.2002.00451.x
pubmed: 11853236
Bellamy JL, Cady RK, Durham PL (2006) Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 46:24–33. https://doi.org/10.1111/j.1526-4610.2006.00294.x
doi: 10.1111/j.1526-4610.2006.00294.x
pubmed: 16412148
Hansen JM, Petersen J, Wienecke T et al (2009) Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers. J Headache Pain 10:85–91. https://doi.org/10.1007/s10194-009-0102-x
doi: 10.1007/s10194-009-0102-x
pubmed: 19266171
pmcid: 3451653
Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56. https://doi.org/10.1002/ana.410330109
doi: 10.1002/ana.410330109
pubmed: 8388188
Fanciullacci M, Alessandri M, Figini M et al (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119–123
doi: 10.1016/0304-3959(94)00097-X
Cernuda-Morollón E, Larrosa D, Ramón C et al (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81:1191–1196. https://doi.org/10.1212/WNL.0b013e3182a6cb72
doi: 10.1212/WNL.0b013e3182a6cb72
pubmed: 23975872
Leira Y, Ameijeira P, Domínguez C et al (2019) Periodontal inflammation is related to increased serum calcitonin gene-related peptide levels in patients with chronic migraine. J Periodontol 90:1088–1095. https://doi.org/10.1002/JPER.19-0051
doi: 10.1002/JPER.19-0051
pubmed: 31070784
Ashina M, Bendtsen L, Jensen R et al (2000) Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 86:133–138. https://doi.org/10.1016/s0304-3959(00)00232-3
doi: 10.1016/s0304-3959(00)00232-3
pubmed: 10779670
Kamm K, Straube A, Ruscheweyh R (2019) Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Cephalalgia Int J Headache 39:1535–1543. https://doi.org/10.1177/0333102419856640
doi: 10.1177/0333102419856640
Kamm K, Straube A, Ruscheweyh R (2020) Baseline tear fluid CGRP is elevated in active cluster headache patients as long as they have not taken attack abortive medication Cephalalgia. Int J Headache:333102420949858. https://doi.org/10.1177/0333102420949858
Tvedskov JF, Lipka K, Ashina M et al (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561–568. https://doi.org/10.1002/ana.20605
doi: 10.1002/ana.20605
pubmed: 16178016
Wild V, Messlinger K, Fischer MJM (2015) Hydrogen sulfide determines HNO-induced stimulation of trigeminal afferents. Neurosci Lett 602:104–109. https://doi.org/10.1016/j.neulet.2015.06.056
doi: 10.1016/j.neulet.2015.06.056
pubmed: 26149232
Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the trigeminal system in migraine. Headache 59:659–681. https://doi.org/10.1111/head.13529
doi: 10.1111/head.13529
pubmed: 30982963
pmcid: 6593989
Dux M, Babes A, Manchen J et al (2020) High-dose phenylephrine increases meningeal blood flow through TRPV1 receptor activation and release of calcitonin gene-related peptide. Eur J Pain Lond Engl 24:383–397. https://doi.org/10.1002/ejp.1495
doi: 10.1002/ejp.1495
Messlinger K, Balcziak LK (1996) Russo AF (2020) cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators. J Neural Transm Vienna Austria 127:431–444. https://doi.org/10.1007/s00702-020-02161-7
doi: 10.1007/s00702-020-02161-7
Messlinger K (2018) The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system. J Headache Pain 19:22. https://doi.org/10.1186/s10194-018-0848-0
doi: 10.1186/s10194-018-0848-0
pubmed: 29532195
pmcid: 5847494
Rascol MM, Izard JY (1976) The subdural neurothelium of the cranial meninges in man. Anat Rec 186:429–436. https://doi.org/10.1002/ar.1091860308
doi: 10.1002/ar.1091860308
pubmed: 999036
Fricke B, Andres KH, Von Düring M (2001) Nerve fibers innervating the cranial and spinal meninges: morphology of nerve fiber terminals and their structural integration. Microsc Res Tech 53:96–105. https://doi.org/10.1002/jemt.1074
doi: 10.1002/jemt.1074
pubmed: 11301485
Liu Z, Liu Q, Cai H et al (2011) Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion. Regul Pept 171:19–25. https://doi.org/10.1016/j.regpep.2011.05.014
doi: 10.1016/j.regpep.2011.05.014
pubmed: 21718723
Plog BA, Dashnaw ML, Hitomi E et al (2015) Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci 35:518–526. https://doi.org/10.1523/JNEUROSCI.3742-14.2015
doi: 10.1523/JNEUROSCI.3742-14.2015
pubmed: 25589747
pmcid: 4293408
Tumani H, Huss A, Bachhuber F (2017) The cerebrospinal fluid and barriers - anatomic and physiologic considerations. Handb Clin Neurol 146:21–32. https://doi.org/10.1016/B978-0-12-804279-3.00002-2
doi: 10.1016/B978-0-12-804279-3.00002-2
pubmed: 29110772
Cheng Y, Haorah J (2019) How does the brain remove its waste metabolites from within? Int J Physiol Pathophysiol Pharmacol 11:238–249
pubmed: 31993098
pmcid: 6971497
Krisch B (1988) Ultrastructure of the meninges at the site of penetration of veins through the dura mater, with particular reference to Pacchionian granulations. Investigations in the rat and two species of new-world monkeys (Cebus apella, Callitrix jacchus). Cell Tissue Res 251:621–631. https://doi.org/10.1007/BF00214011
doi: 10.1007/BF00214011
pubmed: 3130190
von Düring M, Andres KH (1991) Sensory nerve fiber terminals in the arachnoid granulations of non-human primates. Neurosci Lett 127:121–124
doi: 10.1016/0304-3940(91)90909-D
Ito K, Yamada M, Horiuchi T, Hongo K (2020) Microanatomy of the dura mater at the craniovertebral junction and spinal region for safe and effective surgical treatment. J Neurosurg Spine:1–7. https://doi.org/10.3171/2020.1.SPINE191424
Hansen JM, Ashina M (2014) Calcitonin gene-related peptide and migraine with aura: a systematic review. Cephalalgia Int J Headache 34:695–707. https://doi.org/10.1177/0333102413520084
doi: 10.1177/0333102413520084
Schou WS, Ashina S, Amin FM et al (2017) Calcitonin gene-related peptide and pain: a systematic review. J Headache Pain 18:34. https://doi.org/10.1186/s10194-017-0741-2
doi: 10.1186/s10194-017-0741-2
pubmed: 28303458
pmcid: 5355411
Ye F, Deng P-Y, Li D et al (2007) Involvement of endothelial cell-derived CGRP in heat stress-induced protection of endothelial function. Vasc Pharmacol 46:238–246. https://doi.org/10.1016/j.vph.2006.10.008
doi: 10.1016/j.vph.2006.10.008
Gangula PRR, Chauhan M, Reed L, Yallampalli C (2009) Age-related changes in dorsal root ganglia, circulating and vascular calcitonin gene-related peptide (CGRP) concentrations in female rats: effect of female sex steroid hormones. Neurosci Lett 454:118–123. https://doi.org/10.1016/j.neulet.2009.02.068
doi: 10.1016/j.neulet.2009.02.068
pubmed: 19429067
pmcid: 2782373
Yang J, Li Y, Hu C (2011) Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-κB signaling pathway in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36:972–978. https://doi.org/10.3969/j.issn.1672-7347.2011.10.007
doi: 10.3969/j.issn.1672-7347.2011.10.007
pubmed: 22086008
Zhang H, He S, Hu Y, Zheng H (2016) Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine. Acupunct Med J Br Med Acupunct Soc 34:463–470. https://doi.org/10.1136/acupmed-2016-011113
doi: 10.1136/acupmed-2016-011113
van Dongen RM, Zielman R, Noga M et al (2017) Migraine biomarkers in cerebrospinal fluid: a systematic review and meta-analysis. Cephalalgia Int J Headache 37:49–63. https://doi.org/10.1177/0333102415625614
doi: 10.1177/0333102415625614
Wang X (1991) changes of calcitonin gene-related peptide (CGRP) concentrations in CSF in patients with cerebrovascular disorders. Zhonghua Shen Jing Jing Shen Ke Za Zhi 24(186):133–134
pubmed: 1889317
Hoffmann O, Keilwerth N, Bille MB et al (2002) Triptans reduce the inflammatory response in bacterial meningitis. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 22:988–996. https://doi.org/10.1097/00004647-200208000-00010
doi: 10.1097/00004647-200208000-00010
Bründl E, Proescholdt M, Störr E-M et al (2020) Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage-a feasibility series. Neurosurg Rev. https://doi.org/10.1007/s10143-020-01333-z
Szabó K (1990) The cranial venous system in the rat: anatomical pattern and ontogenetic development. I Basal drainage Anat Embryol (Berl) 182:225–234. https://doi.org/10.1007/BF00185516
doi: 10.1007/BF00185516
Szabó K (1995) The cranial venous system in the rat: anatomical pattern and ontogenetic development. II. Dorsal drainage. Ann Anat Anat Anz Off Organ Anat Ges 177:313–322. https://doi.org/10.1016/S0940-9602(11)80371-7
doi: 10.1016/S0940-9602(11)80371-7
Kraenzlin ME, Ch’ng JLC, Mulderry PK et al (1985) Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones. Regul Pept 10:189–197. https://doi.org/10.1016/0167-0115(85)90013-8
doi: 10.1016/0167-0115(85)90013-8
pubmed: 3922013
Braslis KG, Shulkes A, Fletcher DR, Hardy KJ (1988) Pharmacokinetics and organ-specific metabolism of calcitonin gene-related peptide in sheep. J Endocrinol 118:25–31. https://doi.org/10.1677/joe.0.1180025
doi: 10.1677/joe.0.1180025
pubmed: 3261772
Kurosawa M, Messlinger K, Pawlak M, Schmidt RF (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114:1397–1402
doi: 10.1111/j.1476-5381.1995.tb13361.x
Levy D, Burstein R, Strassman AM (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58:698–705. https://doi.org/10.1002/ana.20619
doi: 10.1002/ana.20619
pubmed: 16240341
Jansen-Olesen I, Mortensen A, Edvinsson L (1996) Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia Int J Headache 16:310–316
doi: 10.1046/j.1468-2982.1996.1605310.x
Edvinsson L, Nilsson E, Jansen-Olesen I (2007) Inhibitory effect of BIBN4096BS, CGRP (8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 150:633–640. https://doi.org/10.1038/sj.bjp.0707134
doi: 10.1038/sj.bjp.0707134
pubmed: 17245362
pmcid: 2189771
Cumberbatch MJ, Williamson DJ, Mason GS et al (1999) Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol 126:1478–1486. https://doi.org/10.1038/sj.bjp.0702444
doi: 10.1038/sj.bjp.0702444
pubmed: 10217543
pmcid: 1565916
Akerman S, Williamson DJ, Kaube H, Goadsby PJ (2002) Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 137:62–68. https://doi.org/10.1038/sj.bjp.0704842
doi: 10.1038/sj.bjp.0704842
pubmed: 12183331
pmcid: 1573468
Tröltzsch M, Denekas T, Messlinger K (2007) The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow. Eur J Pharmacol 562:103–110. https://doi.org/10.1016/j.ejphar.2007.01.058
doi: 10.1016/j.ejphar.2007.01.058
pubmed: 17349622
Fischer MJM, Uchida S, Messlinger K (2010) Measurement of meningeal blood vessel diameter in vivo with a plug-in for ImageJ. Microvasc Res 80:258–266. https://doi.org/10.1016/j.mvr.2010.04.004
doi: 10.1016/j.mvr.2010.04.004
pubmed: 20406650
von Düring M, Bauersachs M, Böhmer B et al (1990) Neuropeptide Y- and substance P-like immunoreactive nerve fibers in the rat dura mater encephali. Anat Embryol (Berl) 182:363–373
doi: 10.1007/BF02433496
Haines DE, Harkey HL, al-Mefty O (1993) The “subdural” space: a new look at an outdated concept. Neurosurgery 32:111–120. https://doi.org/10.1227/00006123-199301000-00017
doi: 10.1227/00006123-199301000-00017
pubmed: 8421539